Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-41.52	33.03	56.47
Graham Fair Price	-1.27	616.87	624.82
PEG	1597.04	9.24	-0.54
Price/Book	5.83	0.80	0.76
Price/Cash Flow	-56.56	34.69	-79.85
Prices/Earnings	-6.00	44.30	47.12
Price/Sales	10.12	0.94	0.85
Price/FCF	-56.56	34.69	-79.85
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	5.72	0.29	0.27
Operating Margin	213.18	0.03	< 0.005
ROA	20.07	< 0.005	< 0.005
ROE	< 0.005	< 0.005	12.59
ROIC	< 0.005	< 0.005	190.08
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	-0.11	1.26	-91.27
Dividends QOQ	15.31	-0.95	-93.80
EBIT QOQ	-0.83	2.11	152.54
EPS QOQ	-0.87	0.05	-94.46
FCF QOQ	-1.12	3.51	214.90
Revenue QOQ	-0.03	< 0.005	75.63
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	92.21	81.16	-11.98
Days Sales Outstanding (DSO)	18.77	19.94	6.24
Inventory Turnover	0.98	1.11	13.62
Debt/Capitalization	0.33	0.29	-12.37
Quick Ratio	0.15	0.35	136.85
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	2080.46	1935.79	-6.95
Cash	-135.19	108.18	-19.98
Capex	-7.92	-31.68	-299.94
Free Cash Flow	-19.69	44.63	126.70
Revenue	1848.09	1652.58	-10.58
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.21	1.27	4.93
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	20.38	10.42	-48.89
Naive Interpretation	Member

06 - Financial Health · Weak

Rating